ABSTRACT Although the serum lipoprotein fraction Lp(a) has been associated with coronary artery atherosclerosis, its relationship to narrowing of saphenous vein grafts has not previously been elucidated. We therefore measured serum Lp(a) levels in 167 symptomatic patients undergoing cardiac catheterization who had had coronary artery bypass surgery 0.7 to 14.3 years earlier. Lp(a), total cholesterol, and total triglyceride levels were compared with the degree of saphenous vein graft stenosis to test for any association. Serum Lp(a) levels were significantly associated with the degree of stenosis of saphenous vein grafts (r = .24, p = .002). Mean Lp(a) levels (mg/dl) in the 135 patients with stenosis were almost double (32.0 + 32.7 mean ± SD) those in the 32 patients with no graft stenosis (16.7 ± 22.6; p = .002). Graft stenosis was not associated with previous myocardial infarction, hypertension, obesity, diabetes, or smoking. Serum cholesterol levels (mg/dl) were slightly higher in the stenosis group (251.3 ± 69) than in the no-stenosis group (231.8 ± 48.8), but the difference was of borderline significance (p = .06). A stepwise increase in mean Lp(a) was found in groups of patients with increasing vein graft stenosis. At a serum Lp(a) level of 31.6 mg/dl or above, 92% of the patients demonstrated vein graft stenosis. Thus, patients with elevated Lp(a) levels have an increased risk of developing saphenous vein graft stenosis after coronary bypass surgery. Circulation 77, No. 6, 1238-1244 , 1988 AORTOCORONARY BYPASS with saphenous veins is currently the most widely used procedure for revascularizing the myocardium.'-' However, the clinical outlook for such patients has been somewhat dampened by recent reports of long-term patency that indicate that at 10 years or more after surgery, only about 60% of grafts remain patent,3'4 and that nearly one-half of the patent grafts show angiographic evidence of atherosclerosis.4 Several studies have reported an association between elevated serum cholesterol levels and atherosclerosis of vein grafts as determined at autopsy.5 6 Recently, plasma low-density lipoprotein (LDL) levels have been shown to be elevated and plasma high-density lipoprotein (HDL) levels reduced in patients with stenotic grafts more than 10 years after From the
bypass surgery compared with levels in those with no demonstratable graft stenosis.`In this same study, graft stenosis correlated more closely with apolipoprotein B (apo B), the protein portion of LDL, than with LDL cholesterol.
A number of clinical studies have demonstrated a link between stenosis due to atherosclerosis of native coronary arteries and serum Lp(a),'s a lipoprotein fraction originally discovered by Berg, 10 whose chemical properties are similar to those of LDL. "-Such an association has also been shown to exist for stenosis in carotid16 17 and in cerebral arteries. 8 However, to date no study has demonstrated an association between serum Lp(a) levels and stenosis of saphenous vein grafts (SVGs). We therefore initiated a cross-sectional study of a group of symptomatic patients undergoing angiograms who had undergone bypass surgery 0.7 to 14.3 years earlier.
Methods
Clinical history of patient populations. We studied 167 patients undergoing cardiac catheterization at the Cleveland Clinic Foundation from June 1982 to October 1984 because of postoperative symptoms. All had previously undergone coronary artery bypass with implantation of aortocoronary saphe-nous vein grafts. Table 1 details the clinical and angiographic data on this study population. Of note is the fact that grafts bypassing the left anterior descending, the circumflex, and the right coronary artery were distributed equally in this patient population (about 60%). Figure 1 describes the distribution of the length of time between surgery and recatheterization, which ranged up to about 15 years.
We also studied 33 patients who had patent native coronary arteries documented by angiography and who did not have coronary artery bypass surgery. The mean (t SD) age of this group was 58.4 ± 8.8 years and it consisted of 15 men and 18 women.
Coronary cineangiography. For our study all cineangiograms were reviewed by one of the authors (J. K.), who is an experienced angiographer and was blinded to the patients' symptomatic status and lipid findings. The reviewer was inforned of the number and location of all SVGs, and reviewed the cineangiogram only to determine the status of the grafts. The bypass grafts were examined in multiple projections and the degree of stenosis determined in that projection that showed the most severe narrowing. Because studies were done at least 0.7 years postoperatively, intimal remodeling was universal. However, in a nonstenotic vessel no geographic site (from the proximal to the distal anastomosis) was narrower than the size of the native artery it perfused. The diameter of the narrowest location of stenotic grafts was compared with the maximum graft diameter. The stumps of occluded (100% stenosis) grafts were selectively injected or visualized on aortography in the appropriate projection. Persons with multiple grafts had both their mean stenosis (average of percent stenosis of all grafts per person) and maximum stenosis (highest grade of stenosis across all grafts per person) determined. gave a reading of only 1.6 ,ug/ml. To further assess potential cross-reactivity, we measured the plasminogen content conventionally26 in serum samples from 10 cases with the highest Lp(a) levels (mean = 126.0 mg/dl) and from 10 cases giving the lowest Lp(a) levels (mean = 8.53 mg/dl), but found no significant differences in serum plasminogen levels. It is therefore unlikely that differences in serum Lp(a) levels recorded in this study reflect cross-reactivity with plasminogen.
Statistical methods. Most analyses were performed with the mean stenosis value for each person. Since degrees of stenosis of less than 20% were deemed unreliable, we used this percent as our threshold for stenosis, i.e., patients with 0 to 19% stenosis were classified in the no-stenosis group, whereas those with 20% to 100% stenosis were classified in the stenosis group. Other analyses used stenosis as a continuous variable in which patients with no stenosis were classified as 0% stenosis. Comparisons between groups were performed with a nonparametric test, since the distribution of some of the variables [e.g., Lp(a) and triglycerides] were not normally distributed. The Wilcoxon rank-sum test was used to compare continuous variables in the stenosis and no-stenosis groups. 27 Comparisons of categorical variables in stenosis and no-stenosis groups were assessed by chi-square tests. The association between Lp(a) levels and percent stenosis was evaluated with the use of Spearman's rank correlation. The association of Lp(a) with number of stenosed grafts was evaluated by testing the slope of the regression line equal to zero. 27 Stepwise logistic regression28 was used to evaluate simultaneously the relationship of several factors with stenosis vs no stenosis. The BMDP stepwise logistic program was used. 29 Tables, 1983) . The mean time interval between surgery and recatheterization (duration) was 1.8 years longer in the stenosis group than in the no-stenosis group.
Relationships between the presence of SVG stenosis and Lp(a) levels. A significant positive linear correlation (Spearman's rank correlation) was found between serum Lp(a) levels and either mean percent graft stenosis (r = .24, p .002) or maximal percent graft stenosis (r = .20, p = .008). The mean serum Lp(a) level in the stenosis group (32.0 mg/dl) was almost double that in the no-stenosis group (16.7 mg/dl) (table 3; p = .002). However, this difference was highly significant only for men 55 years of age or younger. Nonetheless, the differences for older men and in women, although not statistically significant, were in the same direction as those for the younger men. Although the total serum We considered the possibility that a different association might be present between serum Lp(a) levels and total graft occlusion (100% stenosis) and clinically significant stenosis (defined here as 51% to 99% stenosis). The former could have resulted from thrombosis occurring early after graft insertion, whereas the latter could have resulted from the development of atherosclerosis. However, by the Wilcoxon rank-sum test, no significant differences were detected between the mean serum Lp(a) levels in patients with 51% to 99% stenosis (31.6 + 35.7 mg/dl, n = 59) and those in patients with 100% stenosis (37.9 ± 35.7 mg/dl, n = 39) when expressed as mean stenosis, or between levels in patients with 51% to 99% stenosis (34.1 ± 38.7 mg/dl, n = 20) and those in patients with 100% stenosis (32.2 ± 32.4 mg/dl, n = 101) when expressed as maximum stenosis. Thus, it seems unlikely that the association between serum Lp(a) levels and graft stenosis differs in patients demonstrating partial or Since myocardial infarction had been shown previously to be associated with transient increases in serum Lp(a) levels,3' we tested whether any differences could be detected between mean Lp(a) levels of patients who had experienced a previous myocardial infarction within 30 days of obtaining a blood sample and levels in those not experiencing infarction within this time frame. However, no significant difference in mean Lp(a) values was found, in either the stenosis or the no-stenosis group, between patients with and without a previous myocardial infarction, or for patients with infarction within and out of the 30 day interval. We considered the possibility that drug therapy could affect Lp(a) levels, and therefore assessed whether significant differences existed in Lp(a) levels for patients on or not on the most prevalent drug therapy, i.e., fl-blockers (43% of patients). Again, no significant differences in Lp(a) levels were found in the patients on fl-blockers Logistic regression analysis. Because of the trends noted in some clinical subgroups, we also used logistic regression analysis to examine the relative contribution of Lp(a) and these other factors to stenosis after bypass surgery. Factors considered as potential variables in the model were Lp(a), cholesterol, and triglyceride levels; diabetes; hypertension; and previous myocardial infarction. Interactions of these variables were allowed in the logistic regression, in which the only factor found to be associated significantly with stenosis was Lp(a). The variable next most associated with stenosis (but not significantly, p = .36) was hypertension. The regression model with Lp(a) had a constant term of 0.883 ± 0.274 and a coefficient for Lp(a) of 0.0243 ± 0.0103. The odds ratio for Lp(a) was 1.02 (95% confidence interval, 1.00 to 1.05), which expresses the relative risk of being classified as having stenosis or not having stenosis for a unit increase in Lp(a). That is, for any increase of one unit in Lp(a) there is a 2% increased risk of incurring stenosis. For example, if Lp(a) increases from 20 to 30 mg/dl, there is a 20% increased risk of stenosis.
To determine which values of Lp(a) best predict stenosis, we calculated the sensitivity and specificity of the prediction for various cutpoints of Lp(a). A cutpoint of Lp(a) equal to 31.6 mg/dl or above as an indicator of stenosis results in a specificity of 88% and a sensitivity of 37%. Use of a lower cutpoint gives a lower specificity and higher sensitivity, e.g., for an Lp(a) of 22.6 mg/dl, the specificity is 78% and the sensitivity is 51%. In our study, 92% of patients with an Lp(a) of 31.6 mg/dl or above demonstrated vein graft stenosis.
The ability of Lp(a) to predict stenosis can also be evaluated by calculating the positive predictive value, e.g., the probability of incurring graft stenosis when the serum Lp(a) level is equal to or above the specified cutpoint. The predictive value depends on the pretest probability of stenosis in the group being evaluated. Assuming the pretest probability may be rather large, e.g., 50%, the positive predictive value is 0.76 with a Lp(a) cutpoint of 31.6 mg/dl and 0.70 at a cutpoint of 22.6 mg/dl. Therefore, in spite of the low sensitivity of Lp(a) in determining who will have stenosis, the predictive power is high when applied to a group with a large probability of stenosis. Men under 56 years of age with Lp(a) levels of 39 mg/dl or higher had an average score that was 80% higher than the score for those with Lp(a) levels below 39 mg/dl. Discriminant analysis showed Lp(a) to be an independent predictor of coronary heart disease. These results are similar to those found in our present study (table 4) in patients with vein graft stenosis, both in terms of the overall association of elevated Lp(a) with atherosclerosis, and in terms of the increased predictiveness of elevated Lp(a) in patients under 56 years of age. Lp(a) possesses some characteristics similar to LDL, i.e., both are rich in cholesterol, both contain apoB (B-100), both have hydrated densities between serum HDL and LDL levels, 1-'5 35 and both are recognized by the LDL receptor on mesenchymal cells [although Lp(a) is recognized at a lower affinity).36 However, compared with LDL, Lp(a) has a slightly different lipid composition,37 six times more sialic acid,"1 and an additional protein -the Lp(a) specific antigen, apo(a). 12-15, 35 When Lp(a) is subjected to chemical reduction and then to ultracentrifugation, apo(a) is stripped from the particle, leaving a lipoprotein that is very similar to LDL. '4 Lp(a), unlike LDL, is not produced by very low-density lipoprotein catabolism.38 Lp(a) has been associated with chylomicrons, possibly as a result of interactions between postprandial chylomicrons and serum Lp(a). 39 How Lp(a) exerts its atherogenic effects is unknown. However, a number of mechanisms have been proposed based on studies in vitro. Lp(a) interacts with arterial glycosaminoglycans to a greater degree than LDL, which could lead to greater accumulation of Lp(a) in the intima. The association between Lp(a) levels and graft stenosis was strong in spite of certain limitations in our study design. The study population was driven by clinical events that are not necessarily representative of the entire SVG patient population. In particular, the study probably lost those patients who died early due to severe occlusive atherosclerosis and those patients who were asymptomatic and therefore did not undergo recatheterization. In addition, serum lipid and lipoprotein levels were measured at the time of postoperative angiography, which may not necessarily reflect the values at initial surgery or during the postoperative interval on which the development of SVG atherosclerosis may depend. On the other hand, the inability to include asymptomatic patients in the study would be expected to weaken rather than strengthen the positive association. Thus, the level of the association between Lp(a) and graft stenosis measured in this study may be an underestimate of the relationship.
In conclusion, serum Lp(a) is an independent factor associated with stenosis of SVGs. Further studies are needed to determine the effects of specific clinical and pharmacologic interventions on the level of serum Lp(a) and whether such changes will exert an effect on the development of SVG stenosis.
